Skip to content

"Combined novel ultra-diluted bioactive formulation enhances Sodium Stibogluconate efficacy via T cell-mediated cytokine modulation in experimental visceral leishmaniasis".

Nov 2026 · Microbial Pathogenesis · pp. 108919 · 0 citations · 42 references
Medicine

TL;DR

The SSG-udLA combination represents a promising adjunctive therapeutic strategy for VL, providing enhanced antileishmanial efficacy, potent immunomodulation and improved safety over conventional monotherapy.

Abstract

Background

Visceral leishmaniasis (VL), caused by Leishmania donovani, is a life-threatening neglected tropical disease that continues to pose a major public health challenge in endemic regions. Although sodium stibogluconate (SSG) has been widely used for VL treatment, its therapeutic efficacy has been undermined by increasing drug resistance and dose-related toxicity. Immunomodulatory interventions, including ultra-diluted Leishmania antigen (udLA), may enhance host defense mechanisms and improve treatment outcomes.

Objective

This study aimed to evaluate the antileishmanial efficacy, immunomodulatory effects and safety of SSG in combination with udLA in a BALB/c mouse model of VL.

Methods

BALB/c mice infected with L. donovani were treated with SSG (low and high dose), udLA alone, or combinations of SSG and udLA. Parasite burden was quantified using Leishman-Donovan Units and quantitative PCR. Immunological assessments included analysis of CD4+ and CD8+ T-cell populations, reactive oxygen species (ROS), nitric oxide (NO) production, cytokine profiling and expression of iNOS and NF-κB genes. Hepatic and renal function markers were evaluated to determine treatment-associated toxicity.

Results

All treatment groups showed significant reductions in parasite burden compared with infected controls; however, the SSG+udLA combination achieved the greatest protection. Combination therapy significantly enhanced host immune responses, evidenced by increased CD4+ and CD8+ T-cell activation, elevated ROS and NO production and upregulated iNOS and NF-κB expression. Cytokine analysis demonstrated a strong Th1-skewed immune response, characterized by increased IFN-γ, TNF-α and IL-17 levels and reduced IL-10, IL-13 and IL-27 expression. Furthermore, combination therapy using udLA and SSG (low dose) normalized liver and kidney functions however, at higher dose of SSG liver toxicity was reported.

Conclusion

The SSG-udLA combination represents a promising adjunctive therapeutic strategy for VL, providing enhanced antileishmanial efficacy, potent immunomodulation and improved safety over conventional monotherapy.

View source

Similar papers

Open access Sep 2026

Antileishmanial, immunomodulatory, and pro-regenerative effects of a TC2-SS topical formulation in Leishmania braziliensis cutaneous leishmaniasis. In vitro and in vivo studies

Leishmania braziliensis cutaneous leishmaniasis (CL) remains a major public health challenge due to the toxicity, variable efficacy, and emerging resistance associated with systemic therapies. However, few topical candidates have been successfully developed despite growing guideline support for local treatment in many...

E. Quiceno, Julián Agudelo, Y. Upegui et al. · 0 citations
Open access Nov 2026

Stage-dependent activity of curcumin-rosmarinic acid against Leishmania donovani: Synergy in amastigotes

Background Leishmania donovani causes visceral leishmaniasis, a severe and fatal parasitic disease that affects the world’s most impoverished populations. Iron metabolism is fundamental in parasite survival and host immunity. In this study, we investigated the potential use of iron-chelating compounds to inhibit intrac...

Christine Achiaa Antwi Moore, J. K. Donkor, L. Yamthe et al. · 0 citations
Open access Sep 2026

Efficacy and Pharmacokinetics of Guanidine Derivative LQOF-G2 in an In Vivo Leishmania (Viannia) braziliensis Model

Background/Objectives: Due to their toxicity and the limited efficacy of current therapies, Leishmaniases represent a major public health challenge. The search for new treatments is urgent. LQOF-G2 is a synthetic guanidine compound whose in vitro leishmanicidal potential has already been investigated by our group. The...

Klinger Antônio da França Rodrigues, Luana Ribeiro dos Anjos, Mércya Lopes Braga et al. · 0 citations
Open access Jan 2026

Preventive Immunomodulatory Effects of Doxycycline and Hyperbaric Oxygen Therapy on Serum Tumor Necrosis Factor‐α and Interleukin‐6 Levels in a Rat Model of Malaria

Background Malaria remains a major global health problem causing morbidity and mortality. Although doxycycline is widely used as an effective malaria chemoprophylactic agent, its use is limited in certain populations (doxycycline should not be given to children under 8 years of age and pregnant women). These limitation...

Risma Risma, I. Kurniawan, D. Pratiknya et al. · 0 citations
Open access Sep 2026

Immunomodulatory activity of Bryonia alba 6C and 30C in sheep red blood cell-immunised mice: Insights from humoral and delayed-type hypersensitivity responses

Background: Malnutrition and infectious diseases compromise immune responses, increasing vulnerability to infections. The introduction of plant-derived immunomodulators, such as Bryonia alba (Bry. alba), is attracting attention due to their lower side effects compared with chemical drugs. In Homoeopathy, Bry. alba has...

Abanti Goswami, Narasimha Kumar Gv, Vara Prasad Saka et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.